Edwards Lifescns (EW)
$72.80
1.56 (2.14%)
EW Stock Quote Delayed 30 Minutes
7 Leading MedTech Stocks for Next-Gen Health Solutions
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$71.35
Market Cap
41.88B
PE Ratio
10.45
EPS
6.9653
Volume (Avg. Vol.)
5.44M
Day's Range
$70.78 - $72.29
52-Week Range
$58.93 - $96.12
Dividend & Yield
N/A (N/A)
EW Stock Predictions, Articles, and Edwards Lifescns News
EW Stock Earnings: Edwards Lifesciences Beats EPS, Misses Revenue for Q2 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! It's time to start off Friday with a breakdown of the biggest pre-market stock movers traders need to know about!
Collect Income on This Medical Device Company in May
We have been managing a position in Boston Scientific (NYSE:BSX) since early mid-February of this year. BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.
3 Stocks to Watch on Wednesday: Edwards Lifesciences Corp (EW), Illumina, Inc. (ILMN) and Tesla Inc (TSLA)
Edwards Lifesciences (EW) and Illumina (ILMN) reported their quarterly earnings results, while Tesla (TSLA) is being accused of stiffing its workers of overtime.
3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Edwards Lifesciences Corp (EW) and Motorola Solutions Inc (MSI)
Amgen (AMGN) posted underwhelming earnings, Edwards Lifesciences (EW) posts strong 2017 revenue and Motorola Solutions (MSI) expects 2018 EPS to beat estimates.
Edwards Lifesciences (EW) Ranking Raised to Buy on Robust Earnings Growth
Edwards Lifesciences (NYSE:EW) is ranked as a Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week.
Edwards Lifesciences (EW) Upgraded to Buy on Improving Sales Growth
Portfolio Grader currently ranks Edwards Lifesciences (NYSE:EW) a Buy. The approach to fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week. EW has been upgraded from a Hold to a Buy in the last week.
Industry Group Rank Metrics Limit Edwards Lifesciences (EW) Ratings Upgrade to Hold
With a $21.7 billion market value, Edwards Lifesciences (NYSE:EW) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the ranking for EW by Portfolio Grader places it 76 among the 164 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 366 among the 785 companies in the sector, and number 2,386 in the nearly 5,000 company Portfolio Grader universe.
